Nivatrotamab
Nivatrotamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Nivatrotamab is under investigation in clinical trial NCT03860207 (Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3f8-bsab) in Patients With Relapsed/refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers).
| Trade Name | Nivatrotamab |
| Generic | Nivatrotamab |
| Nivatrotamab Other Names | Hu3F8-BsAb, Nivatrotamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Nivatrotamab
